TGThe Guardian·2hHealth
score+0.60
FDA panel considers a first-of-its-kind flu vaccine using mRNA technology
Original
FDA panel considers a first-of-its-kind flu vaccine using mRNA technology
“Forward-looking language emphasizing innovation and regulatory progress; positions mRNA technology as pandemic-tested solution for flu prevention.”